Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Infigratinib for Children Aged 3 to 17 with Achondroplasia
GermanyStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
GermanyStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
GermanyStudy of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment
GermanyStudy on the Safety and Effects of IMG-007 for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
GermanyStudy on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema
GermanyStudy of V940 and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
GermanyStudy of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors
GermanyStudy of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer
GermanyStudy on Upadacitinib for Pain Management in Patients with Psoriatic Arthritis
GermanyStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
